SCHEMBL24012442

SCHEMBL24012442

CCOCCOCCOCCCNC(=O)c1ccc2nonc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ NPC1 O15118 2/20 0.61
▸ SMN1; SMN2 Q16637 4/20 0.59
▸ HTT P42858 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ MAPT P10636 3/20 0.55
▸ TP53 P04637 1/20 0.55
▸ KMT2A Q03164 4/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ MEN1 O00255 2/20 0.53
▸ ADORA3 P0DMS8 1/20 0.52
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ ADORA1 P30542 1/20 0.52
▸ DRD3 P35462 4/20 0.51
▸ DRD2 P14416 3/20 0.50
▸ HDAC3 O15379 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21806100 0.83 HDAC3 (0.49) HPGDRAB9ANPC1SMN1; SMN2HTT
SCHEMBL13248219 0.81 ADORA3 (0.55) HPGDNPC1SMN1; SMN2HTTALDH1A1
SCHEMBL13056379 0.81 ADORA3 (0.55) NPC1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL13248218 0.80 ADORA3 (0.54) HPGDNPC1SMN1; SMN2TP53ADORA3
SCHEMBL24012380 0.79 MAOB (0.50) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL13248222 0.79 ADORA3 (0.56) HPGDNPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL13753935 0.79 ADORA3 (0.65) HPGDALDH1A1MAPTTP53ADORA3
SCHEMBL13056382 0.78 HDAC3 (0.50) HPGDNPC1SMN1; SMN2ALDH1A1ADORA3
SCHEMBL30265292 0.76 HTT (0.64) HPGDRAB9ANPC1SMN1; SMN2HTT
SCHEMBL6028978 0.76 ADORA3 (0.62) HPGDRAB9ANPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210349101-A1 COUMARIN-BASED CROSSLINKING REAGENTS VENTANA MEDICAL SYSTEMS, INC. 2021-11-11 — — US disclosed
Send feedback